BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16353545)

  • 1. [Some immunological aspects in the reaccional states of Hansen disease].
    Rada E; Nacarid A; Convit J
    Invest Clin; 2005 Dec; 46(4):381-9. PubMed ID: 16353545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine patterns of immunologically mediated tissue damage.
    Yamamura M; Wang XH; Ohmen JD; Uyemura K; Rea TH; Bloom BR; Modlin RL
    J Immunol; 1992 Aug; 149(4):1470-5. PubMed ID: 1500726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
    Legendre DP; Muzny CA; Swiatlo E
    Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of leprosy/Hansen's disease in the early 21st century.
    Worobec SM
    Dermatol Ther; 2009; 22(6):518-37. PubMed ID: 19889136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increase in nitric oxide concentrations in serum and mononuclear cell cultures from patients with Type II reaction state of Hansen's disease].
    Rada E; Marzal M; Aranzazu N; Convit J
    Invest Clin; 2003 Jun; 44(2):129-36. PubMed ID: 12815843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leprosy Reactions: Experience in the Puerto Rico Hansen's Disease Population.
    Rodriguez-Rivera DV; Pelet-Del Toro NM; Quintero-Noriega AL
    P R Health Sci J; 2023 Sep; 42(3):197-202. PubMed ID: 37709675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema nodosum leprosum: reactional leprosy.
    Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
    Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal reaction to Hansen's disease.
    Jih MH; Kimyai-Asadi A; Levis WR
    J Drugs Dermatol; 2002 Jul; 1(1):70-1. PubMed ID: 12847760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophils in Leprosy.
    Schmitz V; Tavares IF; Pignataro P; Machado AM; Pacheco FDS; Dos Santos JB; da Silva CO; Sarno EN
    Front Immunol; 2019; 10():495. PubMed ID: 30949168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and immunological features of leprosy.
    Walker SL; Lockwood DN
    Br Med Bull; 2006; 77-78():103-21. PubMed ID: 17090777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions.
    Zaheer SA; Misra RS; Sharma AK; Beena KR; Kar HK; Mukherjee A; Mukherjee R; Walia R; Talwar GP
    Lepr Rev; 1993 Mar; 64(1):7-14. PubMed ID: 8464320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy type 1 (reversal) reactions and their management.
    Walker SL; Lockwood DN
    Lepr Rev; 2008 Dec; 79(4):372-86. PubMed ID: 19274984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year experience with type 1 and type 2 reactions in Hansen disease at a US travel clinic.
    Jacob JT; Kozarsky P; Dismukes R; Bynoe V; Margoles L; Leonard M; Tellez I; Franco-Paredes C
    Am J Trop Med Hyg; 2008 Sep; 79(3):452-4. PubMed ID: 18784242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Pearls: Leprosy Reactions.
    Wu J; Boggild AK
    J Cutan Med Surg; 2016 Sep; 20(5):484-5. PubMed ID: 27060010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve in reversal reaction.
    Job CK
    Indian J Lepr; 1996; 68(1):43-7. PubMed ID: 8727113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.